Roche is hungry, not starving for M&A

Share this article:

Roche has no immediate plans for a mega deal. CEO Severin Schwan tells Reuters that the Swiss firm will be looking for small acquisitions and partnerships, a strategy it has had in place for some time, and which includes its July purchase of biotech Seragon for $1.7 billion.

Schwan says Roche evaluates potential moves based on how it would affect the balance between external opportunities and internal ones. “It can't be that we have to put important internal opportunities on ice because of too-expensive acquisitions,” he says.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.